Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
MDAI Quote, Financials, Valuation and Earnings
Last price:
$2.67
Seasonality move
:
-30.07%
Day range:
$2.67 - $2.82
52-week range:
$0.82 - $3.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.79x
P/B ratio:
--
Volume:
519.6K
Avg. volume:
675.8K
1-year change:
44.92%
Market cap:
$69.8M
Revenue:
$29.6M
EPS (TTM):
-$0.54
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $15.2M | $25.4M | $18.1M | $29.6M | |
| Revenue Growth (YoY) | -- | -- | 66.47% | -28.82% | 63.83% | |
| Cost of Revenues | -- | $8.2M | $14.5M | $10.2M | $16.3M | |
| Gross Profit | -- | $7.1M | $10.8M | $7.9M | $13.3M | |
| Gross Profit Margin | -- | 46.28% | 42.72% | 43.64% | 44.87% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $11.2M | $13.5M | $20.9M | $19.9M | |
| Other Inc / (Exp) | -- | $110K | -$180K | -$8M | -$5.5M | |
| Operating Expenses | -- | $11.2M | $13.5M | $20.9M | $19.9M | |
| Operating Income | -- | -$4.2M | -$2.6M | -$13M | -$6.6M | |
| Net Interest Expenses | -- | $17K | -- | -- | $3M | |
| EBT. Incl. Unusual Items | -- | -$4.1M | -$2.8M | -$20.8M | -$15M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$98K | $106K | $11K | $271K | |
| Net Income to Company | -- | -$4M | -$2.9M | -$20.9M | -$15.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$4M | -$2.9M | -$20.9M | -$15.3M | |
| Basic EPS (Cont. Ops) | -- | -$0.33 | -$0.19 | -$1.48 | -$0.85 | |
| Diluted EPS (Cont. Ops) | -- | -$0.33 | -$0.19 | -$1.48 | -$0.85 | |
| Weighted Average Basic Share | -- | $15.7M | $15.7M | $14.1M | $17.9M | |
| Weighted Average Diluted Share | -- | $15.7M | $15.7M | $14.1M | $17.9M | |
| EBITDA | -- | -$4.2M | -$2.1M | -$20.1M | -$11.5M | |
| EBIT | -- | -$4.2M | -$2.6M | -$20.8M | -$12.1M | |
| Revenue (Reported) | -- | $15.2M | $25.4M | $18.1M | $29.6M | |
| Operating Income (Reported) | -- | -$4.2M | -$2.6M | -$13M | -$6.6M | |
| Operating Income (Adjusted) | -- | -$4.2M | -$2.6M | -$20.8M | -$12.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $5.8M | $5.1M | $6.3M | $6.7M | |
| Revenue Growth (YoY) | -- | -- | -- | 24.58% | 6.02% | |
| Cost of Revenues | -- | $3.5M | $2.9M | $3.4M | $3.5M | |
| Gross Profit | -- | $2.4M | $2.2M | $2.9M | $3.2M | |
| Gross Profit Margin | -- | 40.9% | 42.95% | 46.55% | 47.23% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $3M | $5.1M | $5.1M | $4.1M | |
| Other Inc / (Exp) | -- | $92K | -$709K | -$778K | $4.5M | |
| Operating Expenses | -- | $3M | $5.1M | $5.1M | $4.1M | |
| Operating Income | -- | -$621K | -$2.9M | -$2.1M | -$896K | |
| Net Interest Expenses | -- | $4K | -- | $262K | $601K | |
| EBT. Incl. Unusual Items | -- | -$533K | -$3.6M | -$3.2M | $3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$5K | $46K | $22K | $71K | |
| Net Income to Company | -- | -$528K | -$3.6M | -$3.2M | $2.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$528K | -$3.6M | -$3.2M | $2.9M | |
| Basic EPS (Cont. Ops) | -- | -$0.03 | -$0.23 | -$0.19 | $0.13 | |
| Diluted EPS (Cont. Ops) | -- | -$0.03 | -$0.23 | -$0.19 | $0.11 | |
| Weighted Average Basic Share | -- | $15.7M | $15.7M | $16.6M | $23M | |
| Weighted Average Diluted Share | -- | $15.7M | $15.7M | $16.6M | $24M | |
| EBITDA | -- | -$489K | -$2.7M | -$2M | -$753K | |
| EBIT | -- | -$621K | -$2.9M | -$2.1M | -$896K | |
| Revenue (Reported) | -- | $5.8M | $5.1M | $6.3M | $6.7M | |
| Operating Income (Reported) | -- | -$621K | -$2.9M | -$2.1M | -$896K | |
| Operating Income (Adjusted) | -- | -$621K | -$2.9M | -$2.1M | -$896K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $24.1M | $19.3M | $30M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $13.8M | $10.7M | $16.5M | |
| Gross Profit | -- | -- | $10.3M | $8.6M | $13.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $15.8M | $20.9M | $18.8M | |
| Other Inc / (Exp) | -- | $92K | -$638K | -$8.1M | -$268K | |
| Operating Expenses | -- | -- | $15.8M | $20.9M | $18.8M | |
| Operating Income | -- | -- | -$5.5M | -$12.2M | -$5.3M | |
| Net Interest Expenses | -- | $4K | -- | $134K | $3.3M | |
| EBT. Incl. Unusual Items | -- | -- | -$6.1M | -$20.5M | -$8.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $141K | -$13K | $320K | |
| Net Income to Company | -- | -- | -- | -$20.5M | -$9.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$6.3M | -$20.5M | -$9.2M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.40 | -$1.38 | -$0.52 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.40 | -$1.38 | -$0.54 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$5M | -$19.4M | -$10.3M | |
| EBIT | -- | -- | -$5.5M | -$20.1M | -$10.8M | |
| Revenue (Reported) | -- | -- | $24.1M | $19.3M | $30M | |
| Operating Income (Reported) | -- | -- | -$5.5M | -$12.2M | -$5.3M | |
| Operating Income (Adjusted) | -- | -- | -$5.5M | -$20.1M | -$10.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $5.8M | $5.1M | $6.3M | $6.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $3.5M | $2.9M | $3.4M | $3.5M | |
| Gross Profit | -- | $2.4M | $2.2M | $2.9M | $3.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $3M | $5.1M | $5.1M | $4.1M | |
| Other Inc / (Exp) | -- | $92K | -$709K | -$778K | $4.5M | |
| Operating Expenses | -- | $3M | $5.1M | $5.1M | $4.1M | |
| Operating Income | -- | -$621K | -$2.9M | -$2.1M | -$896K | |
| Net Interest Expenses | -- | $4K | -- | $262K | $601K | |
| EBT. Incl. Unusual Items | -- | -$533K | -$3.6M | -$3.2M | $3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$5K | $46K | $22K | $71K | |
| Net Income to Company | -- | -$528K | -$3.6M | -$3.2M | $2.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$528K | -$3.6M | -$3.2M | $2.9M | |
| Basic EPS (Cont. Ops) | -- | -$0.03 | -$0.23 | -$0.19 | $0.13 | |
| Diluted EPS (Cont. Ops) | -- | -$0.03 | -$0.23 | -$0.19 | $0.11 | |
| Weighted Average Basic Share | -- | $15.7M | $15.7M | $16.6M | $23M | |
| Weighted Average Diluted Share | -- | $15.7M | $15.7M | $16.6M | $24M | |
| EBITDA | -- | -$489K | -$2.7M | -$2M | -$753K | |
| EBIT | -- | -$621K | -$2.9M | -$2.1M | -$896K | |
| Revenue (Reported) | -- | $5.8M | $5.1M | $6.3M | $6.7M | |
| Operating Income (Reported) | -- | -$621K | -$2.9M | -$2.1M | -$896K | |
| Operating Income (Adjusted) | -- | -$621K | -$2.9M | -$2.1M | -$896K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $16.1M | $14.2M | $4.8M | $5.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $1.4M | $2.3M | $2.3M | $2.5M | |
| Inventory | -- | -- | -- | $230K | $425K | |
| Prepaid Expenses | -- | -- | $331K | $1.5M | $1.3M | |
| Other Current Assets | -- | $840K | $270K | $801K | $746K | |
| Total Current Assets | -- | $18.5M | $17.7M | $9.9M | $10.1M | |
| Property Plant And Equipment | -- | $32K | $1M | $790K | $2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $40K | -- | -- | -- | |
| Total Assets | -- | $18.5M | $18.7M | $10.7M | $12.1M | |
| Accounts Payable | -- | $1.4M | $2.8M | $2.7M | $4M | |
| Accrued Expenses | -- | $907K | $1.9M | $3.5M | $2.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $680K | $853K | $201K | |
| Other Current Liabilities | -- | $186K | $129K | $1.8M | $6.5M | |
| Total Current Liabilities | -- | $4.8M | $6.4M | $12.4M | $17.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $4.8M | $6.7M | $12.4M | $19.3M | |
| Common Stock | -- | $135K | $1K | $2K | $2K | |
| Other Common Equity Adj | -- | -- | -- | $12K | $3K | |
| Common Equity | -- | $13.8M | $12M | -$1.7M | -$7.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $13.8M | $12M | -$1.7M | -$7.3M | |
| Total Liabilities and Equity | -- | $18.5M | $18.7M | $10.7M | $12.1M | |
| Cash and Short Terms | -- | $16.1M | $14.2M | $4.8M | $5.2M | |
| Total Debt | -- | $583K | $175K | $436K | $2.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $10.3M | $10.2M | $14.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $1.9M | $1.8M | $2.1M | |
| Inventory | -- | -- | -- | $228K | $437K | |
| Prepaid Expenses | -- | -- | -- | $1.6M | $1.3M | |
| Other Current Assets | -- | -- | $741K | $1.1M | $840K | |
| Total Current Assets | -- | -- | $13.3M | $14.9M | $18.7M | |
| Property Plant And Equipment | -- | -- | $854K | $599K | $2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $14.2M | $15.5M | $20.7M | |
| Accounts Payable | -- | -- | $2M | $3.3M | $3.1M | |
| Accrued Expenses | -- | -- | $733K | $3.2M | $3.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $244K | |
| Current Portion Of Capital Lease Obligations | -- | -- | $791K | $660K | $474K | |
| Other Current Liabilities | -- | -- | $113K | $1.8M | $5.1M | |
| Total Current Liabilities | -- | -- | $5.4M | $17.5M | $13.3M | |
| Long-Term Debt | -- | -- | -- | -- | $7.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $5.5M | $17.5M | $22.3M | |
| Common Stock | -- | -- | $136K | $2K | $2K | |
| Other Common Equity Adj | -- | -- | -- | $10K | $20K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $8.7M | -$2M | -$1.6M | |
| Total Liabilities and Equity | -- | -- | $14.2M | $15.5M | $20.7M | |
| Cash and Short Terms | -- | -- | $10.3M | $10.2M | $14.1M | |
| Total Debt | -- | -- | $71K | $5.8M | $7.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$4M | -$2.9M | -$20.9M | -$15.3M | |
| Depreciation & Amoritzation | -- | $1K | $568K | $722K | $588K | |
| Stock-Based Compensation | -- | $1.4M | $1.2M | $1.2M | $1M | |
| Change in Accounts Receivable | -- | $1.2M | -$1.4M | $566K | -$159K | |
| Change in Inventories | -- | -- | -- | -$230K | -$195K | |
| Cash From Operations | -- | -$2.9M | -$1.2M | -$13.2M | -$9.2M | |
| Capital Expenditures | -- | $7K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$7K | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $13.1M | |
| Long-Term Debt Repaid | -- | -$701K | -$785K | -$483K | -$7.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $660K | -- | |
| Cash From Financing | -- | $13.9M | -$785K | $3.8M | $9.6M | |
| Beginning Cash (CF) | -- | $5.1M | $16.1M | $14.2M | $4.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $11M | -$1.9M | -$9.4M | $376K | |
| Ending Cash (CF) | -- | $16.1M | $14.2M | $4.8M | $5.2M | |
| Levered Free Cash Flow | -- | -$2.9M | -$1.2M | -$13.2M | -$9.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$528K | -$3.6M | -$3.2M | $2.9M | |
| Depreciation & Amoritzation | -- | $132K | $175K | $191K | $143K | |
| Stock-Based Compensation | -- | $333K | $300K | $283K | $200K | |
| Change in Accounts Receivable | -- | -$1.3M | $640K | $518K | $402K | |
| Change in Inventories | -- | -- | -- | $2K | -$12K | |
| Cash From Operations | -- | -$1.2M | -$3.8M | -$2.7M | -$1.5M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $5.6M | $8.3M | |
| Long-Term Debt Repaid | -- | -$477K | -$104K | -$218K | -$1.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -$477K | -$104K | $8M | $10.4M | |
| Beginning Cash (CF) | -- | $16.1M | $14.2M | $4.8M | $5.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | $1K | -$2K | $17K | |
| Additions / Reductions | -- | -$1.6M | -$3.9M | $5.4M | $8.9M | |
| Ending Cash (CF) | -- | $14.5M | $10.3M | $10.2M | $14.1M | |
| Levered Free Cash Flow | -- | -$1.2M | -$3.8M | -$2.7M | -$1.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$20.5M | -$9.2M | |
| Depreciation & Amoritzation | -- | -- | -- | $738K | $540K | |
| Stock-Based Compensation | -- | $333K | $633K | $1.2M | $949K | |
| Change in Accounts Receivable | -- | -- | -- | $444K | -$275K | |
| Change in Inventories | -- | -- | -- | -$228K | -$209K | |
| Cash From Operations | -- | -- | -- | -$12.2M | -$8M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $5.6M | $15.8M | |
| Long-Term Debt Repaid | -- | -- | -- | -$597K | -$8.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $12M | $11.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$168K | $3.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$12.2M | -$8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$528K | -$3.6M | -$3.2M | $2.9M | |
| Depreciation & Amoritzation | -- | $132K | $175K | $191K | $143K | |
| Stock-Based Compensation | -- | $333K | $300K | $283K | $200K | |
| Change in Accounts Receivable | -- | -$1.3M | $640K | $518K | $402K | |
| Change in Inventories | -- | -- | -- | $2K | -$12K | |
| Cash From Operations | -- | -$1.2M | -$3.8M | -$2.7M | -$1.5M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $5.6M | $8.3M | |
| Long-Term Debt Repaid | -- | -$477K | -$104K | -$218K | -$1.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -$477K | -$104K | $8M | $10.4M | |
| Beginning Cash (CF) | -- | $16.1M | $14.2M | $4.8M | $5.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | $1K | -$2K | $17K | |
| Additions / Reductions | -- | -$1.6M | -$3.9M | $5.4M | $8.9M | |
| Ending Cash (CF) | -- | $14.5M | $10.3M | $10.2M | $14.1M | |
| Levered Free Cash Flow | -- | -$1.2M | -$3.8M | -$2.7M | -$1.5M | |
Get MDAI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MDAI
Sector
P/E ratio
--
23.88x
PEG ratio
-0.01x
0.00x
P/B ratio
--
1.80x
Price / LTM sales
1.79x
1.65x
Growth Metrics
MDAI
Sector
Revenue growth
6.02%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
--
8.01%
Earnings forecast
-$0.08
-$0.20
Profitability
MDAI
Sector
Profitability FY 2024
$13.3M
$47.5M
Return on invested capital
-427.95%
-16.26%
Return on assets
-62.42%
-13.27%
Return on equity
-4727.7%
-18.61%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
12
Estimated Next Earnings Date
Aug
12
Balance Sheet
MDAI
Sector
Total cash
$14.1M
$35.5M
Short term investments
--
$29.7M
Total assets
$12.1M
$106.9M
Long term debt
$7.8M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
